Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Durant

Cancer

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cancer|May 1, 1991
If it quacksJ R Durant
Cancer|May 15, 1990
Overview. Current status of clinical trialsJ R Durant
Cancer|April 1, 1972
Planning for cancer centers. Workshop 3 summaryJ R Durant
Cancer|August 1, 1973
Development of four-drug BCNU combination chemotherapy regimensJ R Durant, H E Lessner
Cancer|September 1, 1981
Evidence that estrogen-receptor-negative, progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptorA M Sarrif, J R Durant
Cancer|December 11, 1975
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphomaJ R Durant, V Loeb, R Dorfman, et al.
Cancer|December 15, 1983
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's diseaseA A Bartolucci, C Liu, J R Durant, et al.
Cancer|July 1, 1979
Unusual manifestations of non-Hodgkin's lymphomaA M Elisei, M J Norgard, J R Durant, et al.
Cancer|March 1, 1975
The pathologic behavior of primary vaginal carcinoma and its relationship to cervical cancerT M Murad, J R Durant, W A Maddox, et al.
Cancer|August 1, 1979
The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinomaS Lowenbraun, A Bartolucci, R V Smalley, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer|May 1, 1991
If it quacksJ R Durant
Cancer|May 15, 1990
Overview. Current status of clinical trialsJ R Durant
Cancer|April 1, 1972
Planning for cancer centers. Workshop 3 summaryJ R Durant
Cancer|August 1, 1973
Development of four-drug BCNU combination chemotherapy regimensJ R Durant, H E Lessner
Cancer|September 1, 1981
Evidence that estrogen-receptor-negative, progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptorA M Sarrif, J R Durant
Cancer|December 11, 1975
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphomaJ R Durant, V Loeb, R Dorfman, et al.
Cancer|December 15, 1983
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's diseaseA A Bartolucci, C Liu, J R Durant, et al.
Cancer|July 1, 1979
Unusual manifestations of non-Hodgkin's lymphomaA M Elisei, M J Norgard, J R Durant, et al.
Cancer|March 1, 1975
The pathologic behavior of primary vaginal carcinoma and its relationship to cervical cancerT M Murad, J R Durant, W A Maddox, et al.
Cancer|August 1, 1979
The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinomaS Lowenbraun, A Bartolucci, R V Smalley, et al.
Pageof 2